Why Pro-Rata Rights Can Decide a UK Fintech Round

UK fintech down-rounds eased in Q1 2026, but bridge and extension capital remains meaningful, giving existing investors more leverage in constrained financings. Broad follow-on rights can fill the allocation needed by a new lead, while pay-to-play can shift protection and influence towards investors that fund the next round.

The control fight is moving below the valuation line

On 26 August 2026, venture commentator Milan Bilimoria made a blunt point about follow-on rights: every pro-rata right is a claim on every future financing round. Grant enough of them and, by Series B, there may be little room left for the new lead investor the company needs. That warning matters in UK fintech now. Halfmeyer Ventures reported that bridge and extension rounds represented 16.6% of cash raised in Q2 2025, up from 11.8% a year earlier. Although 86% of sampled Q1 2026 term sheets were up-rounds, with 3% flat and 11% down, constrained rounds still give existing backers unusual power over allocation.

The central mistake is to view valuation as the whole negotiation. In a flat round, where the price per share does not increase, or an extension round, where a company adds money to an existing financing, the more decisive question can be: who has the right to buy the available shares? A new lead may need a meaningful allocation to justify its work and risk. If incumbent rights consume that allocation, the lead may not be able to enter on terms that work.

Its UK data shows why extension-round allocation can matter even as down-round rates ease. Photo: Ann H / Pexels, Pexels licence (free commercial use).

Pro-rata is not harmless simply because it is common

Pro-rata rights, meaning a right to buy enough shares in a later round to maintain an investor's percentage ownership, are often presented as routine investor protection. Investors care because the right protects their stake if the company performs well. Founders may also see it as a reasonable reward for early risk-taking.

Should founders give every investor pro-rata rights? The evidence in the current market points to no. Each individual grant can look small. Their combined effect is not small. If many holders can take their full entitlement, they can collectively absorb the portion of a financing that would otherwise be available to a new lead, strategic investor or employee allocation.

The part most people miss is that this issue is not limited to a down-round. Halfmeyer Ventures recorded a Q1 2026 down-round rate of 11.4%, lower than a roughly 22% peak in 2023. That is encouraging, but it does not remove allocation pressure. A bridge or extension can still rely heavily on insiders, even where the formal valuation has not fallen.

Bilimoria's 26 August 2026 commentary identifies the practical answer: restrict rights through ownership thresholds, cheque-size thresholds or allocation limits. His examples include limiting eligibility to investors with 1-2% ownership or a £100,000-£250,000 investment. The exact boundary is a commercial negotiation. The principle is clearer: do not create more claims than a future round can accommodate.

GI Network's view: founders should stop treating follow-on rights as a courtesy given one investor at a time. They are a forward claim on scarce capacity. Model the next round from the incoming lead backwards, then decide which incumbent rights the company can actually carry.

Start with the allocation waterfall

A useful mental model is an allocation waterfall. It is not a legal formula. It is a sequence for deciding who needs room in the next financing.

First, establish the new lead's required allocation. A lead that cannot receive sufficient ownership may be unable to justify its diligence, pricing risk or role in the round. Second, reserve any employee and strategic allocation the company needs. Only then test the capacity remaining for incumbent participation rights.

This reverses the usual founder instinct. The usual question is, "Which existing investors have pro-rata?" The better question is, "After the lead and essential allocations, how much room is genuinely left?"

Super pro-rata, a right that can allow an investor to take more than its ordinary ownership share, sharpens the problem. The research brief does not identify a completed UK fintech financing in 2025 or 2026 where a named incoming lead was blocked by such claims. That absence matters. Founders should not present this as a universal outcome or an established fact about every UK round. But the structural risk is clear: investors able to take an outsized allocation can leave even less space for a new lead.

This is why a broad right can damage the very company it was meant to protect. A current investor may preserve more ownership in an insider-led extension, but the company may lose the validation, capital capacity or reset that an external lead could have supplied. For founders, the choice is not between respecting current backers and raising new money. It is about setting rules that permit both.

For a broader guide to sizing a raise around proof rather than aspiration, see How Much Should You Raise? Fund the Proof, Not the Fantasy.

His August 2026 warning captures the cumulative cost of granting too many follow-on rights. Photo: Karolina / Pexels, Pexels licence (free commercial use).

Pay-to-play is a governance choice, not just a penalty

Pay-to-play, a provision that makes an investor's protections conditional on joining a specified new financing, is often described as a way to stop investors from sitting out a difficult round while retaining all their benefits. That description is incomplete.

Practical Law, part of Thomson Reuters, provides a UK standard pay-to-play clause in articles of association, updated as of 2026. The clause removes anti-dilution protection, protection intended to reduce the effect of later share issuances on an investor's economic position, if the investor does not participate in the specified funding round.

That changes the stakes in a flat or extension round. A non-participating investor does not merely accept ordinary dilution. It may lose a protection that would otherwise shape its position in a later round. Investors that can and do fund the company may gain relatively greater future influence through ownership and retained protections. In that sense, pay-to-play can function as a governance reset: it can move economic weight and practical influence towards participants.

It should not be treated as automatically enforceable or automatically appropriate. The research brief flags that UK company law, tax-advantaged structures, founder drag-along rights and protective veto rights can affect whether super pro-rata provisions work as intended. The clause's practical force depends on the full governance package and negotiating power, not the label on the term sheet.

Founders should therefore ask four direct questions before accepting pay-to-play. Which investors must participate? What level of participation is required? Which protections are lost if they do not? And does the company retain enough flexibility to admit a new lead? Those are not technical drafting details. They decide who bears the burden of a hard financing.

Its UK pay-to-play clause shows how non-participation can cost more than ordinary dilution. Photo: CQF-Avocat / Pexels, Pexels licence (free commercial use).

The UK signal is mixed, not uniformly bleak

There is an important counterpoint. UK fintech has not become a market of insider-only rescues. Tracxn-reported 2025 financings included Poly's $86 million Series D in December 2025, XY Miners' $70 million Series B in May 2025 and Omnea's $68 million Series B in July 2025. Where new investors provide ample capital, there can be sufficient room for a major lead and existing investors alike. Participation rights matter less when the round is large enough.

That is the dividing line. In a well-supplied up-round, allocation may be manageable. In a smaller extension or flat round, the allocation itself becomes the central negotiation. Founders should not use the existence of large 2025 UK rounds as evidence that their own rights package is harmless. Nor should investors assume that a more difficult round gives them unlimited ability to dictate terms.

The same pattern has relevance beyond the United Kingdom. In India, regulatory pressure on fintech products such as buy now, pay later can make funders more cautious and can increase reliance on existing investor top-ups. The research does not provide hard Indian data on super pro-rata. Still, the read-across is useful: when regulation pushes companies towards extensions rather than clean external up-rounds, incumbent rights become more important.

The UK has a related regulatory backdrop. The research brief cites FCA policy activity on deferred payment credit and £13 billion of buy now, pay later volume in 2024. The point is not that regulation automatically causes a particular financing term. It is that regulatory tightening can alter investor appetite, which can in turn make insider-backed extensions more likely. That is where structural rights gain force.

This is also why a target list is not the same as fundable access. A company needs a credible route to an investor whose allocation can survive the cap-table rules already in place. Read Where Investors Come From: Stop Confusing a Target List With Access.

What founders should do in the next 30-90 days

In the next 30 days, map every investor's follow-on entitlement. Separate ordinary pro-rata, super pro-rata claims, information rights, meaning contractual rights to receive company information, and any pay-to-play consequences. Do not rely on memory or a summary cap table. Review the relevant articles of association and shareholder arrangements.

Build the allocation waterfall for at least three possible outcomes: an extension, a flat round and an up-round. The model should show the incoming lead's required allocation, any employee or strategic reserve, incumbent participation claims and the resulting founder dilution. The research brief does not supply a standard seed-to-Series A ownership target, so companies should not pretend that one universal target exists. Use the actual requirement of the investor being approached.

In the following 30 days, propose guardrails before a financing becomes urgent. These can include eligibility thresholds based on ownership or prior cheque size, caps on participation, and explicit carve-outs for a new lead. A carve-out is a reserved allocation that existing rights cannot consume. The commercial aim is straightforward: preserve a real opening for the investor the company may need next.

By 90 days, ensure the board and major investors understand the trade-off. A pay-to-play proposal should be assessed not just for its ability to raise immediate cash, but for how it redistributes future protections and influence. If an extension is likely, begin lead conversations early enough to test whether the proposed allocation works before the company is negotiating under time pressure.

For founders weighing price against the wider economics of a financing, How Much Company Should You Give Up for Growth Capital, and Who Gets Paid First? is a useful companion.

What investors should do in the next 30-90 days

Investors should review whether their follow-on reserve strategy, meaning capital kept available for later investments in portfolio companies, is aligned with the rights they request. A broad right is valuable only if the investor can use it. If it cannot participate in a stressed financing, a pay-to-play term may expose it to the loss of anti-dilution protection.

Lead investors should state allocation requirements early. Waiting until the term sheet stage to reveal that a meaningful stake is needed can turn an avoidable cap-table issue into a failed process. Existing investors should recognise the same reality: preserving every entitlement may reduce the chance of securing the external capital that benefits the company and their existing investment.

For both sides, the discipline is simple. Price the round, but also allocate it before treating the valuation as settled.

Where GI Network fits

GI Network helps companies prepare for capital discussions by turning a proposed financing into a clear investor-facing allocation plan: identifying the capital requirement, the investor profile sought, the room required for a prospective lead and the issues that may need to be surfaced before introductions. In this situation, that means helping a founder present a coherent next-round strategy rather than approaching investors with a valuation alone. Companies seeking that preparation and relevant investor introductions can apply for Capital.

What to watch next

• Q3 2026 UK financing data: whether bridge and extension rounds remain near or above the 16.6% share of cash raised reported for Q2 2025.
• Q3-Q4 2026 UK fintech term sheets: whether ownership or cheque-size thresholds become more common for pro-rata eligibility.
• By the end of 2026: whether pay-to-play clauses are paired more frequently with clear carve-outs for incoming leads.
• FCA policy developments after 2026: whether further deferred payment credit regulation changes investor appetite for UK fintech exposure.
• Late 2026 financing announcements: whether large external rounds like Poly's December 2025 Series D, XY Miners' May 2025 Series B and Omnea's July 2025 Series B continue to show ample capacity for both new and existing investors.

The next UK fintech term sheet should not be judged only by its valuation. Founders should ask who gets to buy, who loses protection by declining, and whether the company has preserved enough room for the investor it may need most.